Search research articles
Contact Us
Filters
Showing results (201-210 of 222) with videos related to
Page
of 23
Sort By:
Biomedicine Hub
|
May 14, 2021
Propelling Healthcare with Advanced Therapy Medicinal Products: A Policy Discussion
Denis Horgan, Andres Metspalu, Marie-Christine Ouillade, et al.
Medicine
|
October 9, 2015
A French National Survey on Clotting Disorders in Mastocytosis
Ana B Carvalhosa, Achille Aouba, Gandhi Damaj, et al.
The Lancet. Haematology
|
April 21, 2019
Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study
Steven W Pipe, Midori Shima, Michaela Lehle, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 27, 2025
Operationalising a Haemophilia Gene Editing Lexicon for Practical Use
William McKeown, Cedric Hermans, Carmen Unzu, et al.
Thrombosis and Haemostasis
|
September 10, 2021
New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia
Jan Astermark, Cihan Ay, Manuela Carvalho, et al.
Research and Practice in Thrombosis and Haemostasis
|
February 27, 2026
Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trial
Robert Klamroth, Paul E Monahan, Paul Van der Valk, et al.
The Lancet. Haematology
|
January 30, 2023
Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study
Claude Négrier, Johnny Mahlangu, Michaela Lehle, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 22, 2024
A novel gene editing lexicon strategy for the haemophilia community: Research plan for development and preliminary results
Cedric Hermans, Leonard A Valentino, Courtney D Thornburg, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 22, 2022
Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A - A modified Delphi consensus by the ADVANCE Working Group
Robert Klamroth, Cihan Ay, Philippe De Moerloose, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 21, 2023
Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe
Cedric Hermans, Jan Astermark, Manuela Carvalho, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 222) with videos related to
Sort By:
Page
of 23
Biomedicine Hub
|
May 14, 2021
Propelling Healthcare with Advanced Therapy Medicinal Products: A Policy Discussion
Denis Horgan, Andres Metspalu, Marie-Christine Ouillade, et al.
Medicine
|
October 9, 2015
A French National Survey on Clotting Disorders in Mastocytosis
Ana B Carvalhosa, Achille Aouba, Gandhi Damaj, et al.
The Lancet. Haematology
|
April 21, 2019
Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study
Steven W Pipe, Midori Shima, Michaela Lehle, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 27, 2025
Operationalising a Haemophilia Gene Editing Lexicon for Practical Use
William McKeown, Cedric Hermans, Carmen Unzu, et al.
Thrombosis and Haemostasis
|
September 10, 2021
New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia
Jan Astermark, Cihan Ay, Manuela Carvalho, et al.
Research and Practice in Thrombosis and Haemostasis
|
February 27, 2026
Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trial
Robert Klamroth, Paul E Monahan, Paul Van der Valk, et al.
The Lancet. Haematology
|
January 30, 2023
Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study
Claude Négrier, Johnny Mahlangu, Michaela Lehle, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 22, 2024
A novel gene editing lexicon strategy for the haemophilia community: Research plan for development and preliminary results
Cedric Hermans, Leonard A Valentino, Courtney D Thornburg, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 22, 2022
Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A - A modified Delphi consensus by the ADVANCE Working Group
Robert Klamroth, Cihan Ay, Philippe De Moerloose, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 21, 2023
Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe
Cedric Hermans, Jan Astermark, Manuela Carvalho, et al.
Page
of 23